Clinical Trial Update: Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function [Phase 1]

View source ↗

Summary

A Phase 1 single-dose study evaluating Technosphere Inhalation Powder (inhaled insulin) in diabetic subjects with mild or moderate nephropathy compared to diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Nephropathy

Drugs mentioned

• Technosphere Inhalation Powder (inhaled insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Mild Nephropathy, Moderate Nephropathy | Phase 1 | Status: COMPLETED